Lunesta’s Expanded Sales Force Will Focus On Maintenance Use
This article was originally published in The Pink Sheet Daily
Executive Summary
Sepracor said it does not plan to use negative publicity about side effects with Sanofi-Aventis’ Ambien to gain a competitive edge.